Vorübergehend Lüster Verhandeln terizidone mechanism of action so tun als ob Sherlock Holmes Mispend
Terizidone | C14H14N4O4 - PubChem
Pyrazinamide - Wikipedia
Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs - ScienceDirect
Tuberculosis management - Wikiwand
Management of drug-resistant tuberculosis in special sub-populations including those with HIV co-infection, pregnancy, diabetes, organ-specific dysfunction, and in the critically ill - Esmail - Journal of Thoracic Disease
PDF) Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB
Anti tuberculosis drugs
Antimycobacterial Agents - Antibiotics in Laboratory Medicine, 6 Ed.
From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis | Nature Medicine
Pharmacotherapy for multidrug resistant tuberculosis
Mdr tb and newer anti tb drugs
Terizidone - an overview | ScienceDirect Topics
General items
Treatment of tb by arif khan
Diagnosis and Treatment of Drug-Resistant Tuberculosis | Archivos de Bronconeumología
Frontiers | Addressing the Challenges of Tuberculosis: A Brief Historical Account | Pharmacology
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. - Abstract - Europe PMC
Cycloserine - an overview | ScienceDirect Topics
Recent updates on drug resistance in Mycobacterium tuberculosis - Singh - 2020 - Journal of Applied Microbiology - Wiley Online Library
Prothionamide - an overview | ScienceDirect Topics
Terizidone - Wikipedia
Antituberculosis drugs: drug interactions, adverse effects, and use in special situations - part 2: second line drugs
Microorganisms | Free Full-Text | Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid | HTML
Antitubercular Drugs = Site and Mechanism of Action +Online Test (HINDI) GPAT-NIPER- Pharmacist, DI - YouTube
MSF Report "DR-TB drugs under the microscope" by Médecins Sans Frontières France - issuu